RENB Renovaro Inc.

Renovaro Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Large owner William Anderson Wittekind disposed of 350,000 shares, decreasing direct ownership by 9% to 3,353,878 units (SEC Form 4)
4 - RENOVARO INC. (0001527728) (Issuer)
3/12/25 8:12:50 AM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
Director Van Tilburg Maurice was granted 250,000 shares (SEC Form 4)
4 - RENOVARO INC. (0001527728) (Issuer)
2/25/25 1:33:34 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 4 filed by Chief Financial Officer Fuentes Nathen
4 - RENOVARO INC. (0001527728) (Issuer)
2/25/25 1:29:46 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 3 filed by new insider Fuentes Nathen
3 - RENOVARO INC. (0001527728) (Issuer)
1/13/25 4:17:02 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 4 filed by Director Collins Mark Anthony
4 - RENOVARO INC. (0001527728) (Issuer)
11/7/24 12:18:54 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 4 filed by Director Calder Douglas W
4 - RENOVARO INC. (0001527728) (Issuer)
11/6/24 4:54:39 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 4 filed by Interim CFO Tarsh Simon
4 - RENOVARO INC. (0001527728) (Issuer)
11/6/24 4:34:21 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 4 filed by Director Mcnulty James A
4 - RENOVARO INC. (0001527728) (Issuer)
11/6/24 3:25:02 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 3 filed by new insider Van Tilburg Maurice
3 - RENOVARO INC. (0001527728) (Issuer)
11/5/24 11:57:10 AM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 3 filed by new insider Collins Mark Anthony
3 - RENOVARO INC. (0001527728) (Issuer)
10/31/24 5:12:29 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care

Renovaro Inc. SEC Filings

Renovaro Inc. filed SEC Form 8-K: Leadership Update
8-K - RENOVARO INC. (0001527728) (Filer)
6/5/25 4:02:04 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 10-Q filed by Renovaro Inc.
10-Q - RENOVARO INC. (0001527728) (Filer)
5/15/25 4:31:00 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
Renovaro Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - RENOVARO INC. (0001527728) (Filer)
4/18/25 5:00:41 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
Renovaro Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events
8-K - RENOVARO INC. (0001527728) (Filer)
4/10/25 4:55:50 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
Renovaro Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - RENOVARO INC. (0001527728) (Filer)
2/28/25 4:05:41 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
SEC Form 10-Q filed by Renovaro Inc.
10-Q - RENOVARO INC. (0001527728) (Filer)
2/19/25 4:02:47 PM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
Amendment: SEC Form 10-Q/A filed by Renovaro Inc.
10-Q/A - RENOVARO INC. (0001527728) (Filer)
2/19/25 9:00:38 AM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
Amendment: SEC Form 10-K/A filed by Renovaro Inc.
10-K/A - RENOVARO INC. (0001527728) (Filer)
2/19/25 8:55:44 AM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
Amendment: SEC Form 10-Q/A filed by Renovaro Inc.
10-Q/A - RENOVARO INC. (0001527728) (Filer)
2/19/25 8:50:47 AM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
Renovaro Inc. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8-K - RENOVARO INC. (0001527728) (Filer)
2/19/25 8:45:21 AM ET
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care

Renovaro Inc.

Recent Analyst Ratings for Renovaro Inc.

Renovaro Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Large owner William Anderson Wittekind disposed of 350,000 shares, decreasing direct ownership by 9% to 3,353,878 units (SEC Form 4)

Director Van Tilburg Maurice was granted 250,000 shares (SEC Form 4)

SEC Form 4 filed by Chief Financial Officer Fuentes Nathen

SEC Form 3 filed by new insider Fuentes Nathen

SEC Form 4 filed by Director Collins Mark Anthony

SEC Form 4 filed by Director Calder Douglas W

SEC Form 4 filed by Interim CFO Tarsh Simon

SEC Form 4 filed by Director Mcnulty James A

SEC Form 3 filed by new insider Van Tilburg Maurice

SEC Form 3 filed by new insider Collins Mark Anthony

Renovaro Inc. SEC Filings

Renovaro Inc. filed SEC Form 8-K: Leadership Update

SEC Form 10-Q filed by Renovaro Inc.

Renovaro Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Renovaro Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events

Renovaro Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 10-Q filed by Renovaro Inc.

Amendment: SEC Form 10-Q/A filed by Renovaro Inc.

Amendment: SEC Form 10-K/A filed by Renovaro Inc.

Amendment: SEC Form 10-Q/A filed by Renovaro Inc.

Renovaro Inc. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review